Lombard Odier Asset Management (Switzerland)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-607,760	Closed	-$1.91M	–	422
2022 Q4	$1.91M	Sell	607,760 -74,540	-11%	-$289K	0.15%	125
2022 Q3	$3.34M	Sell	682,300 -96,469	-12%	-$496K	0.28%	82
2022 Q2	$3.22M	Sell	778,769 -81,933	-10%	-$354K	0.27%	90
2022 Q1	$5M	Sell	860,702 -679,292	-44%	-$4.04M	0.39%	62
2021 Q4	$11.6M	Buy	1,539,994 +130,258	+9%	+$1.13M	0.74%	50
2021 Q3	$12.7M	Buy	1,409,736 +202,795	+17%	+$2M	0.79%	54
2021 Q2	$14.4M	Buy	1,206,941 +358,512	+42%	+$4.06M	0.73%	53
2021 Q1	$10.6M	Buy	+848,429	New	+$11.4M	0.71%	52

Other funds holding SGMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s SGMO Position: Q1 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2023, closing a stake of 607,760 shares — an estimated $1.91M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in SGMO in Q1 2021 and held it in 8 quarters. The position peaked at $14.4M in Q2 2021. 179 funds tracked by Wall St. Rank hold SGMO as of Q1 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 607,760 SANGAMO THERAPEUTICS INC shares in Q1 2023, an estimated $1.91M.
Lombard Odier Asset Management (Switzerland) first reported a position in SANGAMO THERAPEUTICS INC in Q1 2021 and held it in 8 quarters.
Lombard Odier Asset Management (Switzerland)'s SANGAMO THERAPEUTICS INC position peaked at $14.4M in Q2 2021.
179 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 15 May 2023.